Tevogen (TVGN) Total Debt (2023 - 2026)
Tevogen's (TVGN) quarterly Total Debt came in at $6.4 million in Q2 2026, up 5.77% on a YoY basis from $6.1 million in Q2 2025, and down 20.51% quarter-over-quarter from $8.1 million in Q1 2026.
Analysis
Tevogen (TVGN) Total Debt (2023 - 2026) Analysis & Trends
Tevogen (TVGN) has reported Total Debt for 4 consecutive years, with $6.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Debt rose 5.77% year-over-year to $6.4 million; the trailing twelve-month figure through Jun 2026 stood at $6.4 million (up 5.77% YoY), and the FY2025 full-year result was $6.1 million, up 128.25% from the prior year.
- Total Debt retreated to $6.4 million in Q2 2026 per TVGN's latest filing, from $8.1 million in the prior quarter.
- Across five years, Total Debt topped out at $80.7 million in Q4 2023 and bottomed at $625694.0 in Q2 2023.
- Historically, Total Debt has averaged $9.8 million across 4 years, with a median of $4.7 million in 2025.
- The widest YoY moves for Total Debt: up 325.68% in 2024, down 96.72% in 2024.
- Over 4 years, Total Debt stood at $80.7 million in 2023, then sank by 96.72% to $2.7 million in 2024, then soared by 128.25% to $6.1 million in 2025, then gained by 5.77% to $6.4 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $6.4 million, $8.1 million, and $6.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 586.20 Mn |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 156.40 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 50.15 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | 112.43 Mn |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 93.88 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 847.62 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Tevogen | 27.76 Mn | 27.76 Mn | - | 6.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.40 Mn |
| Mar 31, 2026 | 8.05 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | 6.05 Mn |
| Jun 30, 2025 | 6.05 Mn |
| Mar 31, 2025 | 4.65 Mn |
| Dec 31, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.66 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 80.71 Mn |
| Sep 30, 2023 | 625,694.00 |
| Jun 30, 2023 | 625,694.00 |